...
首页> 外文期刊>BMC Ophthalmology >Visual outcomes of Visian ICL implantation for high myopia in patients with shallow anterior chamber depth
【24h】

Visual outcomes of Visian ICL implantation for high myopia in patients with shallow anterior chamber depth

机译:浅前房深度患者高度近视的Visian ICL植入的视觉效果

获取原文
           

摘要

High myopia with shallow anterior chamber depth (ACD less than 2.8?mm) is not rare. This observational study aims to evaluate visual outcomes after implantation of the Visian Implantable Collamer Lens with a central hole (ICL V4c) in these patients. A prospective cohort of consecutive 51 eyes of 31 patients (20 to 42?years old) was followed for at least 12?months (average 15.35?±?4.90?months, rangers from 12 to 25?months). The preoperative ACD was 2.74?±?0.04?mm (2.65 to 2.79?mm). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), intraocular pressure (IOP), manifest refraction, vault, and endothelial cell density (ECD) were measured during the follow-ups after surgery. All surgeries were performed safely and no complication was observed during the follow-ups. At the last follow-up, the safety index (postoperative CDVA / preoperative CDVA) was 1.33?±?0.60 and the efficacy index (postoperative UDVA / preoperative CDVA) was 1.14?±?0.54. After the surgery, no eye had decreased CDVA and 59% (30 eyes) of the eyes gained at least one line. Forty-seven eyes (92%) were within ±1.0 D and 35 eyes (69%) were within ±0.5 D of the attempted refraction. The mean postoperative vault was 380.00?±?152.84?μm (90 to 700?μm). The ECD was reduced by 8.38?±?0.06% as compared to the preoperative value (p??0.001). No significant change was observed in IOP (p?=?0.061) at the last follow-up. Ultrasound Biomicroscopy (UBM) showed none of the eyes had trabecular-iris angle closed. In this prospective observational study, ICL V4c implantation in patients with high myopia and shallow ACD achieved satisfying and stable visual outcomes. Its long-term safety and stability require further investigation. This trial was retrospectively registered on 05/08/2018 under the number ( ChiCTR1800017594 ).
机译:高度近视和浅浅的前房深度(ACD小于2.8?mm)并不罕见。这项观察性研究旨在评估在这些患者中植入带有中心孔的Visian植入式护目镜(ICL V4c)后的视觉效果。对31名患者(年龄在20至42岁之间)的连续51只眼睛进行了前瞻性队列研究,随访时间至少为12个月(平均15.35个月±4.90个月,范围为12到25个月。术前ACD为2.74?±?0.04?mm(2.65至2.79?mm)。在手术后的随访期间,测量未矫正的远视力(UDVA),矫正的远视力(CDVA),眼内压(IOP),明显的屈光度,穹ault和内皮细胞密度(ECD)。所有手术均安全进行,在随访过程中未观察到并发症。在最后一次随访中,安全性指数(术后CDVA /术前CDVA)为1.33?±?0.60,疗效指数(术后UDVA /术前CDVA)为1.14?±?0.54。手术后,没有眼睛的CDVA降低,并且59%(30眼)的眼睛至少获得了一条线。尝试屈光的47眼(92%)在±1.0 D以内,35眼(69%)在±0.5 D以内。术后平均穹顶为380.00±±152.84μm(90至700μm)。与术前相比,ECD降低了8.38±±0.06%(p <0.001)。在最后一次随访中,未观察到IOP的显着变化(p≥0.061)。超声生物显微镜(UBM)显示,没有一只眼睛的小梁虹膜角闭合。在这项前瞻性观察研究中,高度近视和浅ACD患者的ICL V4c植入获得了令人满意的稳定视觉效果。它的长期安全性和稳定性需要进一步研究。该试验已于05/08/2018进行了追溯注册,编号为(ChiCTR1800017594)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号